Pediatrics (also spelled paediatrics or pædiatrics) is the branch of medicine that involves the medical care of infants, children, and adolescents.This report anzlyed the medicines for pediatrics.
Scope of the Report:
This report studies the Pediatrics Medicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pediatrics Medicine market by product type and applications/end industries.
The global Pediatrics Medicine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pediatrics Medicine.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GSK
Novartis
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Enteral
Parenteral
Market Segment by Applications, can be divided into
Respiratory diseases
Infectious diseases
Gastrointestinal diseases
CNS diseases
Oncological diseases
CVDs
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Pediatrics Medicine Market Overview
1.1 Product Overview and Scope of Pediatrics Medicine
1.2 Classification of Pediatrics Medicine by Types
1.2.1 Global Pediatrics Medicine Revenue Comparison by Types (2017-2023)
1.2.2 Global Pediatrics Medicine Revenue Market Share by Types in 2017
1.2.3 Enteral
1.2.4 Parenteral
1.3 Global Pediatrics Medicine Market by Application
1.3.1 Global Pediatrics Medicine Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Respiratory diseases
1.3.3 Infectious diseases
1.3.4 Gastrointestinal diseases
1.3.5 CNS diseases
1.3.6 Oncological diseases
1.3.7 CVDs
1.3.8 Others
1.4 Global Pediatrics Medicine Market by Regions
1.4.1 Global Pediatrics Medicine Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Pediatrics Medicine Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Pediatrics Medicine Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pediatrics Medicine Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Pediatrics Medicine Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pediatrics Medicine Status and Prospect (2013-2023)
1.5 Global Market Size of Pediatrics Medicine (2013-2023)
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Pediatrics Medicine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Pediatrics Medicine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Pediatrics Medicine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Pediatrics Medicine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott
2.5.1 Business Overview
2.5.2 Pediatrics Medicine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
2.6.1 Business Overview
2.6.2 Pediatrics Medicine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cipla
2.7.1 Business Overview
2.7.2 Pediatrics Medicine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cipla Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eisai Pharmaceuticals
2.8.1 Business Overview
2.8.2 Pediatrics Medicine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eisai Pharmaceuticals Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Pediatrics Medicine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.10 F. Hoffman-La Roche
2.10.1 Business Overview
2.10.2 Pediatrics Medicine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 F. Hoffman-La Roche Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.11 Glenmark
2.11.1 Business Overview
2.11.2 Pediatrics Medicine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Glenmark Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.12 Helsinn Healthcare
2.12.1 Business Overview
2.12.2 Pediatrics Medicine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Helsinn Healthcare Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.13 Heron Therapeutics
2.13.1 Business Overview
2.13.2 Pediatrics Medicine Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Heron Therapeutics Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.14 Ipca Laboratories
2.14.1 Business Overview
2.14.2 Pediatrics Medicine Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Ipca Laboratories Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.15 Lupin Pharmaceuticals
2.15.1 Business Overview
2.15.2 Pediatrics Medicine Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Lupin Pharmaceuticals Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.16 Merck Sharp & Dohme
2.16.1 Business Overview
2.16.2 Pediatrics Medicine Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Merck Sharp & Dohme Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.17 RedHill
2.17.1 Business Overview
2.17.2 Pediatrics Medicine Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 RedHill Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.18 Sun Pharmaceutical Industries
2.18.1 Business Overview
2.18.2 Pediatrics Medicine Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.19 Takeda Pharmaceutical
2.19.1 Business Overview
2.19.2 Pediatrics Medicine Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Takeda Pharmaceutical Pediatrics Medicine Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pediatrics Medicine Market Competition, by Players
3.1 Global Pediatrics Medicine Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Pediatrics Medicine Players Market Share
3.2.2 Top 10 Pediatrics Medicine Players Market Share
3.3 Market Competition Trend
4 Global Pediatrics Medicine Market Size by Regions
4.1 Global Pediatrics Medicine Revenue and Market Share by Regions
4.2 North America Pediatrics Medicine Revenue and Growth Rate (2013-2018)
4.3 Europe Pediatrics Medicine Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Pediatrics Medicine Revenue and Growth Rate (2013-2018)
4.5 South America Pediatrics Medicine Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Pediatrics Medicine Revenue and Growth Rate (2013-2018)
5 North America Pediatrics Medicine Revenue by Countries
5.1 North America Pediatrics Medicine Revenue by Countries (2013-2018)
5.2 USA Pediatrics Medicine Revenue and Growth Rate (2013-2018)
5.3 Canada Pediatrics Medicine Revenue and Growth Rate (2013-2018)
5.4 Mexico Pediatrics Medicine Revenue and Growth Rate (2013-2018)
6 Europe Pediatrics Medicine Revenue by Countries
6.1 Europe Pediatrics Medicine Revenue by Countries (2013-2018)
6.2 Germany Pediatrics Medicine Revenue and Growth Rate (2013-2018)
6.3 UK Pediatrics Medicine Revenue and Growth Rate (2013-2018)
6.4 France Pediatrics Medicine Revenue and Growth Rate (2013-2018)
6.5 Russia Pediatrics Medicine Revenue and Growth Rate (2013-2018)
6.6 Italy Pediatrics Medicine Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Pediatrics Medicine Revenue by Countries
7.1 Asia-Pacific Pediatrics Medicine Revenue by Countries (2013-2018)
7.2 China Pediatrics Medicine Revenue and Growth Rate (2013-2018)
7.3 Japan Pediatrics Medicine Revenue and Growth Rate (2013-2018)
7.4 Korea Pediatrics Medicine Revenue and Growth Rate (2013-2018)
7.5 India Pediatrics Medicine Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Pediatrics Medicine Revenue and Growth Rate (2013-2018)
8 South America Pediatrics Medicine Revenue by Countries
8.1 South America Pediatrics Medicine Revenue by Countries (2013-2018)
8.2 Brazil Pediatrics Medicine Revenue and Growth Rate (2013-2018)
8.3 Argentina Pediatrics Medicine Revenue and Growth Rate (2013-2018)
8.4 Colombia Pediatrics Medicine Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Pediatrics Medicine by Countries
9.1 Middle East and Africa Pediatrics Medicine Revenue by Countries (2013-2018)
9.2 Saudi Arabia Pediatrics Medicine Revenue and Growth Rate (2013-2018)
9.3 UAE Pediatrics Medicine Revenue and Growth Rate (2013-2018)
9.4 Egypt Pediatrics Medicine Revenue and Growth Rate (2013-2018)
9.5 Nigeria Pediatrics Medicine Revenue and Growth Rate (2013-2018)
9.6 South Africa Pediatrics Medicine Revenue and Growth Rate (2013-2018)
10 Global Pediatrics Medicine Market Segment by Type
10.1 Global Pediatrics Medicine Revenue and Market Share by Type (2013-2018)
10.2 Global Pediatrics Medicine Market Forecast by Type (2018-2023)
10.3 Enteral Revenue Growth Rate (2013-2023)
10.4 Parenteral Revenue Growth Rate (2013-2023)
11 Global Pediatrics Medicine Market Segment by Application
11.1 Global Pediatrics Medicine Revenue Market Share by Application (2013-2018)
11.2 Pediatrics Medicine Market Forecast by Application (2018-2023)
11.3 Respiratory diseases Revenue Growth (2013-2018)
11.4 Infectious diseases Revenue Growth (2013-2018)
11.5 Gastrointestinal diseases Revenue Growth (2013-2018)
11.6 CNS diseases Revenue Growth (2013-2018)
11.7 Oncological diseases Revenue Growth (2013-2018)
11.8 CVDs Revenue Growth (2013-2018)
11.9 Others Revenue Growth (2013-2018)
12 Global Pediatrics Medicine Market Size Forecast (2018-2023)
12.1 Global Pediatrics Medicine Market Size Forecast (2018-2023)
12.2 Global Pediatrics Medicine Market Forecast by Regions (2018-2023)
12.3 North America Pediatrics Medicine Revenue Market Forecast (2018-2023)
12.4 Europe Pediatrics Medicine Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Pediatrics Medicine Revenue Market Forecast (2018-2023)
12.6 South America Pediatrics Medicine Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Pediatrics Medicine Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Pediatrics Medicine Picture
Table Product Specifications of Pediatrics Medicine
Table Global Pediatrics Medicine and Revenue (Million USD) Market Split by Product Ty